HKB's Mouse Osteoporosis Models provide pharmaceutical researchers with robust platforms for investigating bone loss disorders. Our validated rodent models utilize ovariectomy, glucocorticoid treatment, or genetic approaches to replicate key features of osteoporosis including decreased bone mineral density, trabecular bone loss, and increased fracture risk.